Skip to main content
Top
Published in: International Ophthalmology 1/2012

01-02-2012 | Case Report

Candida dubliniensis endophthalmitis: first case in North America

Authors: Diego G. Espinosa-Heidmann, Brian D. McMillan, P. Rocco Lasala, Jonathan Stanley, Cristoforo R. Larzo

Published in: International Ophthalmology | Issue 1/2012

Login to get access

Abstract

To report an unusual case of endogenous fungal endophthalmitis due to Candida dubliniensis. Interventional case report of a 27-year-old immunocompetent male with loss of vision, dense vitritis, and chorioretinal infiltrates, who underwent a diagnostic pars plana vitrectomy. Microbiology cultures obtained by a diagnostic vitrectomy were positive for the growth of C. dubliniensis. This infectious process was then appropriately treated with intravitreal amphotericin B and systemic fluconazole with resolution of the endophthalmitis. Endogenous fungal endophthalmitis is a condition that can masquerade other more common causes of endophthalmitis. Atypical cases of endophthalmitis may benefit from diagnostic pars plana vitrectomy for prompt diagnosis and treatment.
Literature
1.
go back to reference Shen X, Xu G (2009) Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm 17:148–152PubMedCrossRef Shen X, Xu G (2009) Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm 17:148–152PubMedCrossRef
2.
go back to reference Khan FA, Slain D, Khakoo RA (2007) Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy 27:1711–1721PubMedCrossRef Khan FA, Slain D, Khakoo RA (2007) Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy 27:1711–1721PubMedCrossRef
3.
go back to reference Essman TF, Flynn HW Jr, Smiddy WE, Brod RD, Murray TG, Davis JL, Rubsamen PE (1997) Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 28:185–194PubMed Essman TF, Flynn HW Jr, Smiddy WE, Brod RD, Murray TG, Davis JL, Rubsamen PE (1997) Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 28:185–194PubMed
4.
go back to reference Ness T, Pelz K, Hansen LL (2007) Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand 85:852–856PubMedCrossRef Ness T, Pelz K, Hansen LL (2007) Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand 85:852–856PubMedCrossRef
5.
go back to reference Feman SS, Nichols JC, Chung SM, Theobald TA (2002) Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 100:67–70PubMed Feman SS, Nichols JC, Chung SM, Theobald TA (2002) Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 100:67–70PubMed
6.
go back to reference Scheid LA, Nunes Mario DA, Soares IH, Loreto ES, Santurio JM, Alves SH (2010) DRBC agar: a new tool for Candida dubliniensis identification. Folia Microbiol (Praha) 55:155–158CrossRef Scheid LA, Nunes Mario DA, Soares IH, Loreto ES, Santurio JM, Alves SH (2010) DRBC agar: a new tool for Candida dubliniensis identification. Folia Microbiol (Praha) 55:155–158CrossRef
7.
go back to reference Barnes RA, Vale L (2005) “Spiking” as a rapid method for differentiation of Candida albicans from other yeast species. J Hosp Infect 60:78–80PubMedCrossRef Barnes RA, Vale L (2005) “Spiking” as a rapid method for differentiation of Candida albicans from other yeast species. J Hosp Infect 60:78–80PubMedCrossRef
8.
go back to reference Brandt ME, Harrison LH, Pass M, Sofair AN, Huie S, Li RK, Morrison CJ, Warnock DW, Hajjeh RA (2000) Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 6:46–49PubMed Brandt ME, Harrison LH, Pass M, Sofair AN, Huie S, Li RK, Morrison CJ, Warnock DW, Hajjeh RA (2000) Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 6:46–49PubMed
9.
go back to reference Obi E, Roy A, Bates V, Sandy C (2006) Bilateral chronic fungal dacryocystitis caused by Candida dubliniensis in a neutropenic patient. J Clin Pathol 59:1194–1195PubMedCrossRef Obi E, Roy A, Bates V, Sandy C (2006) Bilateral chronic fungal dacryocystitis caused by Candida dubliniensis in a neutropenic patient. J Clin Pathol 59:1194–1195PubMedCrossRef
10.
go back to reference Loreto ES, Scheid LA, Nogueira CW, Zeni G, Santurio JM, Alves SH (2010) Candida dubliniensis: epidemiology and phenotypic methods for identification. Mycopathologia 169:431–443PubMedCrossRef Loreto ES, Scheid LA, Nogueira CW, Zeni G, Santurio JM, Alves SH (2010) Candida dubliniensis: epidemiology and phenotypic methods for identification. Mycopathologia 169:431–443PubMedCrossRef
11.
go back to reference Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ, Jones RN (2004) In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn Microbiol Infect Dis 48:101–105PubMedCrossRef Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ, Jones RN (2004) In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn Microbiol Infect Dis 48:101–105PubMedCrossRef
12.
go back to reference Campanha NH, Neppelenbroek KH, Spolidorio DM, Spolidorio LC, Pavarina AC (2005) Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis. Oral Dis 11:392–398PubMedCrossRef Campanha NH, Neppelenbroek KH, Spolidorio DM, Spolidorio LC, Pavarina AC (2005) Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis. Oral Dis 11:392–398PubMedCrossRef
13.
go back to reference Chunchanur SK, Nadgir SD, Halesh LH, Patil BS, Kausar Y, Chandrasekhar MR (2009) Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients. Indian J Pathol Microbiol 52:501–504PubMedCrossRef Chunchanur SK, Nadgir SD, Halesh LH, Patil BS, Kausar Y, Chandrasekhar MR (2009) Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients. Indian J Pathol Microbiol 52:501–504PubMedCrossRef
14.
go back to reference Gutierrez J, Morales P, Gonzalez MA, Quindos G (2002) Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 42:207–227PubMedCrossRef Gutierrez J, Morales P, Gonzalez MA, Quindos G (2002) Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 42:207–227PubMedCrossRef
15.
go back to reference Badiee P, Alborzi A, Davarpanah MA, Shakiba E (2010) Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch. Iran Med 13:282–287PubMed Badiee P, Alborzi A, Davarpanah MA, Shakiba E (2010) Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch. Iran Med 13:282–287PubMed
Metadata
Title
Candida dubliniensis endophthalmitis: first case in North America
Authors
Diego G. Espinosa-Heidmann
Brian D. McMillan
P. Rocco Lasala
Jonathan Stanley
Cristoforo R. Larzo
Publication date
01-02-2012
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 1/2012
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-011-9499-8

Other articles of this Issue 1/2012

International Ophthalmology 1/2012 Go to the issue